Doctors often prescribe drugs for anti-clotting and heart patients at risk of clots in the long term, the most famous of these drugs daily dose of aspirin and a few well-known as the "children's aspirin."
The drug reduces the risk of heart attack
But according to the website Health, the American Medical new US study revealed that the drug "Erilinta" the latest anti-clotting drugs, it is possible that the long-term benefit in the prevention of heart attacks and stroke, and reduces related to heart disease deaths.
Dose of the drug at least provide the highest protection
The study led by Professor Marc Sapatten professor heart at Brigham and Women's Hospital at Harvard Medical School in Boston, and included a trace more than 21 thousand people from survivors of heart attacks over the last three years, and in 31 different US states, and during the study replaced the researchers "aspirin children "drug" Erilinta by "60 mg twice daily, and the dose of 90 mg twice daily and other drug and placebo.
The study revealed reduced heart-related deaths in the group dealing with the drug "Erilinta a dose of 90 mg" for the amount of 15% and a reduction in mortality with taking the drug "Erilinta a dose of 60 mg" by 16%, as compared to the group that deals with placebo, as recommended by the study by eating Property at a dose of 90 mg twice daily for the treatment of acute blockage of coronary syndrome, which is a heart disease.